Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evaluation of pirarubicin-cisplatin chemotherapy in the treatment for refractory and recurrent high-grade osteosarcoma: experience of a single institute.
Qi WX, He AN, Tang LN, Shen Z, Yao Y. Qi WX, et al. Med Oncol. 2012 Sep;29(3):2229-33. doi: 10.1007/s12032-011-0021-y. Epub 2011 Jul 7. Med Oncol. 2012. PMID: 21748427 Clinical Trial.
Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials.
Qi WX, Shen Z, Yao Y. Qi WX, et al. J Cancer Res Clin Oncol. 2011 Dec;137(12):1785-90. doi: 10.1007/s00432-011-1052-7. Epub 2011 Sep 14. J Cancer Res Clin Oncol. 2011. PMID: 21915752
Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis.
Qi WX, Tang LN, He AN, Shen Z, Yao Y. Qi WX, et al. J Cancer Res Clin Oncol. 2012 May;138(5):745-51. doi: 10.1007/s00432-012-1155-9. Epub 2012 Jan 19. J Cancer Res Clin Oncol. 2012. PMID: 22258853 Review.
Erlotinib and pemetrexed as maintenance therapy for advanced non-small-cell lung cancer: a systematic review and indirect comparison.
Qi WX, Tang LN, He AN, Shen Z, Lin F, Yao Y. Qi WX, et al. Curr Med Res Opin. 2012 Apr;28(4):643-50. doi: 10.1185/03007995.2012.675880. Epub 2012 Mar 29. Curr Med Res Opin. 2012. PMID: 22414178 Review.
Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.
Qi WX, He AN, Tang LN, Shen Z, Lin F, Yao Y. Qi WX, et al. Jpn J Clin Oncol. 2012 May;42(5):427-31. doi: 10.1093/jjco/hys030. Epub 2012 Mar 26. Jpn J Clin Oncol. 2012. PMID: 22450929
Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.
He A, Qi W, Huang Y, Sun Y, Shen Z, Zhao H, Yang Y, Yao Y. He A, et al. Among authors: qi w. Int J Clin Oncol. 2013 Jun;18(3):498-505. doi: 10.1007/s10147-012-0409-5. Epub 2012 Apr 26. Int J Clin Oncol. 2013. PMID: 22534798
Doublet versus single cytotoxic agent as first-line treatment for elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis.
Qi WX, Tang LN, He AN, Shen Z, Lin F, Yao Y. Qi WX, et al. Lung. 2012 Oct;190(5):477-85. doi: 10.1007/s00408-012-9399-3. Epub 2012 Jun 19. Lung. 2012. PMID: 22711060 Review.
64 results
Jump to page
Feedback